15451901

Source:http://linkedlifedata.com/resource/pubmed/id/15451901

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011860, umls-concept:C0030705, umls-concept:C0184511, umls-concept:C0332307, umls-concept:C1313386, umls-concept:C1999230, umls-concept:C2587213
pubmed:issue	10
pubmed:dateCreated	2004-9-28
pubmed:abstractText	Insulin glulisine is a novel analog of human insulin designed for use as a rapid-acting insulin. This study compared the safety and efficacy of glulisine with regular human insulin (RHI) in combination with NPH insulin.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Isophane, http://linkedlifedata.com/resource/pubmed/chemical/insulin glulisine
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0149-5992
pubmed:author	pubmed-author:DaileyGeorgeG, pubmed-author:MosesRobert GRG, pubmed-author:RosenstockJulioJ, pubmed-author:WaysKirkK
pubmed:copyrightInfo	Copyright 2004 American Diabetes Association
pubmed:issnType	Print
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2363-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:15451901-Aged, pubmed-meshheading:15451901-Blood Glucose, pubmed-meshheading:15451901-Diabetes Mellitus, Type 2, pubmed-meshheading:15451901-Dose-Response Relationship, Drug, pubmed-meshheading:15451901-Drug Administration Schedule, pubmed-meshheading:15451901-Female, pubmed-meshheading:15451901-Follow-Up Studies, pubmed-meshheading:15451901-Hemoglobin A, Glycosylated, pubmed-meshheading:15451901-Humans, pubmed-meshheading:15451901-Hypoglycemia, pubmed-meshheading:15451901-Injections, Subcutaneous, pubmed-meshheading:15451901-Insulin, pubmed-meshheading:15451901-Insulin, Isophane, pubmed-meshheading:15451901-International Cooperation, pubmed-meshheading:15451901-Male, pubmed-meshheading:15451901-Middle Aged, pubmed-meshheading:15451901-Probability, pubmed-meshheading:15451901-Reference Values, pubmed-meshheading:15451901-Risk Assessment, pubmed-meshheading:15451901-Severity of Illness Index, pubmed-meshheading:15451901-Single-Blind Method, pubmed-meshheading:15451901-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.
pubmed:affiliation	Scripps Clinic, 10666 North Torrey Pines Rd., La Jolla, CA 92037, USA. dailey.george@scrippshealth.org
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III